DE60322064D1 - 4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen - Google Patents

4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen

Info

Publication number
DE60322064D1
DE60322064D1 DE60322064T DE60322064T DE60322064D1 DE 60322064 D1 DE60322064 D1 DE 60322064D1 DE 60322064 T DE60322064 T DE 60322064T DE 60322064 T DE60322064 T DE 60322064T DE 60322064 D1 DE60322064 D1 DE 60322064D1
Authority
DE
Germany
Prior art keywords
aminobutane
dithiobis
sulphonate
derivatives
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322064T
Other languages
English (en)
Inventor
Marie-Claude Fournie-Zaluski
Catherine Llorens-Cortes
Bernard P Roques
Pierre Corvol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris 5 Rene Descartes
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0208977A external-priority patent/FR2842522B1/fr
Priority claimed from FR0303425A external-priority patent/FR2852597A1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE60322064D1 publication Critical patent/DE60322064D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60322064T 2002-07-16 2003-07-16 4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen Expired - Lifetime DE60322064D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0208977A FR2842522B1 (fr) 2002-07-16 2002-07-16 Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositons les contenant
FR0303425A FR2852597A1 (fr) 2003-03-20 2003-03-20 Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
PCT/FR2003/002242 WO2004007441A2 (fr) 2002-07-16 2003-07-16 Derives de 4,4' -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant

Publications (1)

Publication Number Publication Date
DE60322064D1 true DE60322064D1 (de) 2008-08-21

Family

ID=30117028

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322064T Expired - Lifetime DE60322064D1 (de) 2002-07-16 2003-07-16 4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen

Country Status (11)

Country Link
US (1) US7235687B2 (de)
EP (1) EP1525188B1 (de)
AT (1) ATE400552T1 (de)
AU (1) AU2003271811A1 (de)
CY (1) CY1109013T1 (de)
DE (1) DE60322064D1 (de)
DK (1) DK1525188T3 (de)
ES (1) ES2309336T3 (de)
PT (1) PT1525188E (de)
SI (1) SI1525188T1 (de)
WO (1) WO2004007441A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080011287A (ko) 2005-04-15 2008-02-01 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
EP2322514A1 (de) * 2009-11-11 2011-05-18 Bayer Schering Pharma Aktiengesellschaft Homoglutaminsäure und Glutaminsäurederivate
EP2439192A1 (de) * 2010-10-07 2012-04-11 Quantum Genomics Verfahren zur Herstellung von (3S,3S') 4,4'-disulfandiylbis (3-aminobutan 1-sulfonsäure)
IN2014DN05787A (de) * 2011-12-21 2015-05-15 Quantum Genomics
EP2722327A1 (de) * 2012-10-22 2014-04-23 Quantum Genomics Kristalline Phase von (3S,3S') 4,4'-disulfandiylbis (3-Aminobutan 1-Sulfonsäure) mit L-Lysin
JP2017532348A (ja) * 2014-10-17 2017-11-02 ユニバーシティ オブ フロリダ リサーチ ファウンデーション 新規な小分子抗癌剤
US10501426B1 (en) 2019-01-11 2019-12-10 King Saud University Synthesis of thiazole derivative as anticancer and anti-antibiotics resistant bacteria agent
CN110845347B (zh) * 2019-11-21 2021-10-15 利尔化学股份有限公司 一种氯代高丝氨酸烷基酯的制备方法
TW202207917A (zh) 2020-05-06 2022-03-01 法商量子基因科技有限公司 包含腦胺肽酶抑制劑、利尿劑及全身性腎素-血管收縮素系統阻斷劑之醫藥組合物
WO2022225712A1 (en) 2021-04-22 2022-10-27 Teva Pharmaceuticals International Gmbh Solid state forms of firibastat and processes for preparation thereof
CN115448833A (zh) * 2022-08-25 2022-12-09 湖北泰盛化工有限公司 一种多官能团脂肪族伯醇衍生物的羟基直接氯代方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773712B1 (fr) 1998-01-16 2000-06-02 Inst Nat Sante Rech Med Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a

Also Published As

Publication number Publication date
US20060135602A1 (en) 2006-06-22
WO2004007441A2 (fr) 2004-01-22
AU2003271811A1 (en) 2004-02-02
SI1525188T1 (sl) 2008-12-31
US7235687B2 (en) 2007-06-26
WO2004007441A3 (fr) 2004-04-08
DK1525188T3 (da) 2008-11-17
EP1525188B1 (de) 2008-07-09
PT1525188E (pt) 2008-10-16
AU2003271811A8 (en) 2004-02-02
ATE400552T1 (de) 2008-07-15
CY1109013T1 (el) 2014-07-02
EP1525188A2 (de) 2005-04-27
ES2309336T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
HUP0204235A2 (hu) Helyettesített glutárimidek és felhasználásuk IL-12 termelés inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MXPA04000577A (es) Derivados de dolastatina 10.
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
SE9903760D0 (sv) New compounds
BR0016543A (pt) Novos derivados de piperidina e piperazina
IL160028A0 (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions containing them and their use in therapy
NO20025450D0 (no) Ny farmasöytisk sammensetning
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
HUP0002247A2 (hu) Proteáz inhibitorok
DE60322064D1 (de) 4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen
SE0302756D0 (sv) Novel Compounds
CY1105939T1 (el) Παραγωγα βενζοθειαζινης και βενζοθεαδιαζινης, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τα πepιεχουν
MXPA04005552A (es) Analogos de vitamina d.
ATE260252T1 (de) Thiocolchicin-derivate mit entzündungshemmender und muskelrelaxierender wirkung
NO20010940D0 (no) TAN-1057 derivater
NO20055754L (no) Kolkisosidanaloger
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
MY135460A (en) Method of stimulating hair growth using benzopyrans
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, , FR

Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC, FR

Owner name: UNIVERSITE PARIS DESCARTES, PARIS, FR